中性细胞细胞外陷和呼吸道疾病
Paul T King1,2, Lovisa Dousha1,2
1Monash Lung, Sleep, Allergy and Immunology, Monash Medical Centre, 246 Clayton Rd, Clayton, Melbourne, VIC 3168, Australia.
Journal of clinical medicine
|April 27, 2024
概括
中性粒细胞外细胞陷 (NETs) 在肺免疫中至关重要,但可以引起炎症和损伤. 准NET可能为COPD和喘等呼吸道疾病提供新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 细胞生物学 细胞生物学
背景情况:
- 中性细胞细胞外陷 (NETs) 和其他白细胞衍生的陷在最初的免疫反应中起着至关重要的作用.
- 这些陷具有高度的炎症性,并与组织损伤有关,特别是在肺系统内,因为其解剖结构促进了气道和气膜空间的延伸.
- 越来越多的研究强调了NET在许多呼吸道疾病中的参与,包括COPD,囊性纤维化,喘,肺炎和肺癌.
研究的目的:
- 提供关于NET在呼吸道疾病中的作用的全面概述.
- 讨论针对NET的潜在治疗策略,以获得临床益处.
- 为了区分NET形成与其他炎症细胞死亡途径.
主要方法:
- 关于NET和呼吸道疾病的当前科学文献的综述.
- 分析与NETs相关的表达和诊断挑战.
- 对NET向疗法的早期临床试验的审查.
主要成果:
- NETs与广泛的呼吸系统疾病有关,包括COPD,囊性纤维化,喘,肺炎,COVID-19和肺癌.
- NET形成的特定机制需要与其他细胞外DNA释放过程区分开来.
- 目前针对NET的治疗干预措施处于临床开发的初始阶段.
结论:
- NETs是各种肺部疾病的发病的一个重要因素.
- 需要准确的诊断方法来区分NET与其他炎症媒介.
- 针对NETs为未来的呼吸道疾病治疗提供了一个有希望的途径,尽管进一步的研究和临床验证至关重要.
更多相关视频
07:36Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues
Published on: August 18, 2023
6.4K
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
596
相关概念视频
01:29Microbiota of the Respiratory Tract
55
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
55
01:14Atypical Pneumonia
84
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:29Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24